Pharmacogenomics of MDR1/ABCB1 Gene: the Influence on Risk and Clinical Outcome of Haematological Malignancies

References

• Evans, W.E. and McLeod, H.L. (2003) "Pharmacogenomics-drug disposition, drug targets, and side effects", N. Engl. J. Med. 348, 538–549.
   PubMed Web of Science ®Google Scholar
• Voso, M.T., D'Alo', F., Putzulu, R., Mele, L., Scardocci, A., Chiusolo, P., Latagliata, R., Lo-Coco, F., Rutella, S., Pagano, L., Hohaus, S. and Leone, G. (2002) "Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia", Blood 100, 2703–2707.
   PubMed Web of Science ®Google Scholar
• Dean, M., Rzhetsky, A. and Allikmets, R. (2001) "The human ATP-binding cassette (ABC) transporter superfamily", Genome Res. 11, 1156–1166.
   PubMed Web of Science ®Google Scholar
• Juliano, R.L. and Ling, V. (1976) "A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants", Biochim. Biophys. Acta 455, 152–162.
   PubMed Web of Science ®Google Scholar
• Goldstein, L.J., Galski, H., Fojo, A., Willingham, M., Lai, S.L., Gazdar, A., Pirker, R., Green, A., Crist, W. and Brodeur, G.M. (1989) "Expression of a multidrug resistance gene in human cancers", J. Natl Cancer Inst. 81, 116–124.
   PubMed Web of Science ®Google Scholar
• Ambdukar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I. and Gottesman, M.M. (1999) "Biochemical, cellular, and pharmacological aspects of the multidrug transporter", Annu. Rev. Pharmacol. Toxicol. 39, 361–398.
   PubMed Web of Science ®Google Scholar
• Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. and Willingham, M.C. (1987) "Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues", Proc. Natl Acad. Sci. USA 84, 7735–7738.
   PubMed Web of Science ®Google Scholar
• Klimecki, W.T., Futscher, B.W., Grogan, T.M. and Dalton, W.S. (1994) "P-glycoprotein expression and function in circulating blood cells from normal volunteers", Blood 83, 2451–2458.
   PubMed Web of Science ®Google Scholar
• Ford, J.M. and Hait, W.N. (1990) "Pharmacology of drugs that alter multidrug resistance in cancer", Pharmacol. Rev. 42, 155–199.
   PubMed Web of Science ®Google Scholar
• Higgins, C.F. and Gottesman, M.M. (1992) "Is the multidrug transporter a flippase?", Trends Biochem. Sci. 17, 18–21.
   PubMed Web of Science ®Google Scholar
• Bolhuis, H., van Veen, H.W., Molenaar, D., Poolman, B., Driessen, A.J. and Konings, W.N. (1996) "Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane", EMBO J. 15, 4239–4245.
   PubMed Web of Science ®Google Scholar
• Hoffman, M.M. and Roepe, P.D. (1997) "Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression", Biochemistry 36, 11153–11168.
   PubMed Web of Science ®Google Scholar
• Penny, J.I. and Campbell, F.C. (1994) "Active transport of benzo[a]pyrene in apical membrane vesicles from normal human intestinal epithelium", Biochim. Biophys. Acta 1226, 232–236.
   PubMed Web of Science ®Google Scholar
• Walle, K.U. and Walle, T. (1999) "Transport of the cook-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyri-dine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps", Carcinogenesis 20, 2153–2157.
   PubMed Web of Science ®Google Scholar
• Mochida, Y, Taguchi, K., Taniguchi, S., Tsuneyoshi, M., Kuwano, H., Tsuzuki, T., Kuwano, M. and Wada, M. (2003) "The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice", Carcinogenesis 24, 1219–1224.
   PubMed Web of Science ®Google Scholar
• Smyth, M.J., Krasovskis, E., Sutton, V.R. and Johnstone, R.W. (1998) "The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis", Proc. Natl Acad. Sci. USA 95, 7024–7029.
   PubMed Web of Science ®Google Scholar
• Gollapud, S. and Gupta, S. (2001) "Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival", J. Clin. Immunol. 21, 420–430.
   PubMed Web of Science ®Google Scholar
• Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M. and Huber, H. (1996) "Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes", Blood 88, 1747–1754.
   PubMed Web of Science ®Google Scholar
• Randolph, G.J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R.M. and Muller, W.A. (1998) "A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels", Proc. Natl Acad. Sci. USA 95, 6924–6929.
   PubMed Web of Science ®Google Scholar
• Bunting, K.D. (2002) "ABC transporters as phenotypic markers and functional regulators of stem cells", Stem. Cells 20, 11–20.
   PubMed Web of Science ®Google Scholar
• Schinkel, A.H., Mayer, U., Wagenaar, E., Mol, C.A., van Deemter, L., Smit, J.J., van der Valk, M.A., Voordouw, A.C., Spits, H., van Tellingen, O., Zijlmans, J.M., Fibbe, W.E. and Borst, P. (1997) "Normal viability and altered pharmaco-kinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins", Proc. Natl Acad. Sci. USA 94, 4028–4033.
   PubMed Web of Science ®Google Scholar
• Meerum Terwogt, J.M., Beijnen, J.H., ten Bokkel Huinink, W.W., Rosing, H. and Schellens, J.H. (1998) "Co-administra-tion of cyclosporin enables oral therapy with paclitaxel", Lancet 352, 285.
   PubMed Web of Science ®Google Scholar
• Malingre, M.M., Beijnen, J.H., Rosing, H., Koopman, F.J., Jewell, R.C., Paul, E.M., Ten Bokkel Huinink, W.W. and Schellens, J.H. (2001) "Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients", Br. J. Cancer 84, 42–47.
   PubMed Web of Science ®Google Scholar
• Taipalensuu, J., Tornblom, H., Lindberg, G., Einarsson, C., Sjoqvist, F., Melhus, H., Garberg, P., Sjostrom, B., Lundgren, B. and Artursson, P. (2001) "Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers", J. Pharmacol. Exp. Ther. 299, 164–170.
   PubMed Web of Science ®Google Scholar
• Tran, C.D., Timmins, P., Conway, B.R. and Irwin, W.J. (2002) "Investigation of the coordinated functional activities of cytochrome P450 3A4 and P-glycoprotein in limiting the absorption of xenobiotics in Caco-2 cells", J. Pharm. Sci. 91, 117–128.
   PubMed Web of Science ®Google Scholar
• Pallis, M. and Russell, N. (2000) "P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic path-way", Blood 95, 2897–2904.
   PubMed Web of Science ®Google Scholar
• Jamroziak, K., Smolewski, P., Balcerczak, E., Cebula, B., Panczyk, M., Szmigielska-Kaplon, A., Mirowski, M. and Robak, T. (2003) "Relation of P-glycoprotein expression, activity and MDR1 gene polymorphism with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukaemia", Hematol. J. 4\(Suppl. 2), 192.
   Google Scholar
• Hotta, T., Tanimura, H., Iwahashi, M., Tani, M., Tsunoda, T., Noguchi, K., Mizobata, S., Arii, K., Terasawa, H., Nakamori, M. and Yamaue, H. (1999) "P-glycoprotein-expressing tumor cells are resistant to anticancer drugs in human gastro-intestinal cancer", Surg. Today 29, 591–596.
   PubMed Web of Science ®Google Scholar
• Ferguson, P.J. and Cheng, Y.C. (1989) "Phenotypic instability of drug sensitivity in a human colon carcinoma cell line", Cancer Res. 49, 1148–1153.
   PubMed Web of Science ®Google Scholar
• Marie, J.P. (2001) "Drug resistance in hematologic malig-nancies", Curr. Opin. Oncol. 13, 463–469.
   PubMed Web of Science ®Google Scholar
• Hirose, M. (2002) "Biology and modulation of multidrug resistance (MDR) in hematological malignancies", Int. J. Hematol. 76\(Suppl. 2), 206–211.
   PubMed Web of Science ®Google Scholar
• Leith, CE, Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Greyer, M.R., Appelbaum, F.R. and Willman, C.L. (1999) "Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study", Blood 94, 1086–1099.
   PubMed Web of Science ®Google Scholar
• Elmer, T., Shuler, U.S., Thiede, C., Schwarz, U.I., Kim, R.B., Gothard, S., Freund, D., Schakel, U., Ehninger, G. and Shaich, M. (2002) "MDR gene polymorphisms affect therapy outcome in acute myeloid leukemia patients", Cancer Res. 62, 4955–4962.
   PubMed Web of Science ®Google Scholar
• Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.M., Head, D.R., Appelbaum, ER. and Willman, C.L. (1997) "Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cyto-genetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study", Blood 89, 3323–3329.
   PubMed Web of Science ®Google Scholar
• Broxterman, H.J., Sonneveld, P., van Putten, W.J., Lankelma, J., Eekman, C.A., Ossenkoppele, G.J., Pinedo, H.M., Lowenberg, B. and Schuurhuis, G.J. (2000) "P-glycoprotein in primary acute myeloid leukemia and treatment outcome ofidarubicin/ cytosine arabinoside-based induction therapy", Leukemia 14, 1018–1024.
   PubMed Web of Science ®Google Scholar
• GIMEMA Group, Tafuri, A., Gregoxj, C., Petrucci, M.T., Ricciardi, M.R., Mancini, M., Cimino, G., Mecucci, C., Tedeschi, A., Fioritoni, G., Ferrara, F., Di Raimondo, F., Gallo, E., Liso, V., Fabbiano, F., Cascavilla, N., Pizzolo, G., Camera, A., Pane, E., Lanza, E., Cilloni, D., Annino, L., Vitale, A., Vegna, M.L., Vignetti, M., Foa, R. and Mandelli, F. (2002) "MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia", Blood 100, 974–981.
   PubMed Web of Science ®Google Scholar
• Wattel, E., Lepelley, P., Merlat, A., Sartiaux, C., Bauters, F., Jouet, J.P. and Fenaux, P. (1995) "Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment", Leukemia 9, 1870–1874.
   PubMed Web of Science ®Google Scholar
• Baer, M.R., George, S.L., Dodge, R.K., O'Loughlin, K.L., Minderman, H., Caligiuri, M.A., Anastasi, J., Powell, B.L., Kolitz, J.E., Schiffer, C.A., Bloomfield, C.D. and Larson, R.A. (2002) "Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720", Blood 100, 1224–1232.
   PubMed Web of Science ®Google Scholar
• Ueda, K., Clark, D.P., Chen, C., Roninson, I.B., Gottesman, M.M. and Pastan, I. (1987) "The human multidrug resistance (mdr1) gene", J. Biol. Chem. 262, 505–508.
   PubMed Web of Science ®Google Scholar
• Chen, C., Clark, D., Ueda, K., Pastan, I., Gottesman, M.M. and Roninson, I.B. (1990) "Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins", J. Biol. Chem. 506, 514.
   Google Scholar
• Ruetz, S. and Gros, P. (1994) "Phosphatidylcholine trans-locase: a physiological role for the mdr2 gene", Cell 77, 1071–1081.
   PubMed Web of Science ®Google Scholar
• Croop, J.M., Raymond, M., Haber, D., Devault, A., Arceci, R.J., Gros, P. and Housman, D.E. (1989) "The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues", Mol. Cell Biol. 9, 1346–1350.
   PubMed Web of Science ®Google Scholar
• Kantharidis, P., El-Osta, S., Silva, M., Lee, G., Hu, X.F. and Zalcberg, J. (2000) "Regulation of MDR1 gene expression: emerging concepts", Drug Resist. Updat. 3, 99–108.
   PubMed Web of Science ®Google Scholar
• Yoshimoto, K., Iwahana, H., Yokogoshi, Y, Saito, S., Shiraishi, M., Sekiya, T., Gottesman, M.M. and Pastan, I. (1988) "A polymorphic HindlIl site within the human multidrug resistance gene 1 (MDR1)", Nucleic Acids Res. 16, 11850.
   PubMed Web of Science ®Google Scholar
• Kioka, N., Tsubota, J., Kakehi, Y, Komano, T., Gottesman, M.M., Pastan, I. and Ueda, K. (1989) "P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries G1y185 with an altered pattern of multidrug resistance", Biochem. Biophys. Res. Commun. 162, 224–231.
   PubMed Web of Science ®Google Scholar
• Stein, U., Walther, W. and Wunderlich, V. (1994) "Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs", Fur. J. Cancer 30A, 1541–1545.
   Web of Science ®Google Scholar
• Mickley, L.A., Lee, J.S., Weng, Z., Zhan, Z., Alvarez, M., Wilson, W., Bates, S.E. and Fojo, T. (1998) "Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors", Blood 91, 1749–1756.
   PubMed Web of Science ®Google Scholar
• Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H.P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. and Brinkmann, U. (2000) "Functional polymorphisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo", Proc. Natl Acad. Sci. USA 97, 3473–3478.
   PubMed Web of Science ®Google Scholar
• Decleves, X., Chevillard, S., Charpentier, C., Vieth, P. and Laplanche, J.L. (2000) "A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein", Hum. Mutat. 15, 486.
   PubMedGoogle Scholar
• Kim, R.B., Leake, B.F., Choo, E.F., Dresser, G.K., Kubba, S.V., Schwarz, U.I., Taylor, A., Xie, HG., McKinsey, J., Zhou, S., Lan, LB., Schuetz, J.D., Schuetz, E.G. and Wilkinson, G.R. (2001) "Identification of functionally variant MDR1 alleles among European Americans and African Americans", Clin. Pharmacol. Ther. 70, 189–199.
   PubMed Web of Science ®Google Scholar
• Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S. and Otsubo, K. (2001) "Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT in healthy Japanese subjects", Pharmacogenetics 11, 175–184.
   PubMedGoogle Scholar
• Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y, Takahashi, M., Kurata, Y, Kigawa, Y., Higuchi, S., Terakawa, N. and Otsubo, K. (2001) "Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene", J. Pharmacol. Exp. Ther. 297, 1137–1143.
   PubMed Web of Science ®Google Scholar
• Kroetz, D.L., Pauli-Magnus, C., Hodges, L.M., Huang, C.C., Kawamoto, M., Johns, S.J., Stryke, D., Ferrin, T.E., DeYoung, J., Taylor, T., Carlson, E.J., Herskowitz, I., Giacomini, K.M. and Clark, A.G. (2003) "Sequence diversity and haplotype structure in the human Al3CB1 (MDR1, multidrug resistance transporter) gene", Pharmacogenetics 13,481–494.
   PubMedGoogle Scholar
• Moriya, Y., Nakamura, T., Horinouchi, M., Sakaeda, T., Tamura, T., Aoyama, N., Shirakawa, T., Gotoh, A., Fujimoto, S., Matsuo, M., Kasuga, M. and Okumura, K. (2002) "Effects of polymorphisms of MDR1, MR131, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects", Biol. Pharm. Bull. 25, 1356–1359.
   PubMed Web of Science ®Google Scholar
• Riva, A. and Kohane, IS. (2002) "SNPper: retrieval and analysis of human SNPs", Bioinformatics 18, 1681–1685.
   PubMed Web of Science ®Google Scholar
• Zheng, H., Webber, S., Zeevi, A., Schuetz, E., Zhang, J., Lamba, J., Bowman, P. and Burckart, G.J. (2002) "The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in paediatric heart transplant patients", Hum. Immunol. 63, 765–770.
   PubMed Web of Science ®Google Scholar
• Horinouchi, M., Sakaeda, T., Nakamura, T., Morita, Y, Tamura, T., Aoyama, N., Kasuga, M. and Okumura, K. (2002) "Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin", Pharm. Res. 19, 1581–1585.
   PubMed Web of Science ®Google Scholar
• Tang, K., Ngoi, S.M., Gwee, P.C., Chua, J.M., Lee, E.J., Chong, S.S. and Lee, C.G. (2002) "Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations", Pharmacogenetics 12, 437–450.
   PubMedGoogle Scholar
• Siddiqui, A., Kerb, R., Weale, M.E., Brinkmarm, U., Smith, A., Goldstein, D.B., Wood, N.W. and Sisodiya, S.M. (2003) "Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1", N. Engl. J. Med. 348, 1442–1448.
   PubMed Web of Science ®Google Scholar
• Ameyaw, M.M., Regateiro, F., Li, T., Liu, X., Tariq, M., Mobarek, A., Thornton, N., Folayan, GO., Githang'a, J., Indalo, A., Ofori-Adjei, D., Price-Evans, D.A. and McLeod, H.L. (2001) "MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity", Pharmacogenetics 11, 217–221.
   PubMedGoogle Scholar
• Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., Schaeffeler, E., Eichelbaum, M., Brinkmarm, U. and Roots, I. (2001) "Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects", Clin. Pharmacol. Then 69, 169–174.
   PubMed Web of Science ®Google Scholar
• Jamroziak, K., Balcerczak, E., IVIlynarski, W., Mirowsld, M. and Robak, T. (2002) "Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population", Pol. J. Pharmacol. 54, 495–500.
   PubMedGoogle Scholar
• Bernal, M.L., Sinues, B., Fanlo, A. and Mayayo, E. (2003) "Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population", Then Drug Monit. 25, 107–111.
   PubMed Web of Science ®Google Scholar
• Balram, C., Sharma, A., Sivathasan, C. and Lee, E.J. (2003) "Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-geno-typic correlates", Br. J. Clin. Pharmacol. 56, 78–83.
   PubMed Web of Science ®Google Scholar
• Schaeffeler, E., Eichelbaum, M., Brinkmann, U., Penger, A., Asante-Poku, S., Zanger, U.M. and Schwab, M. (2001) "Frequency of C3435T polymorphism of MDR1 gene in African people", Lancet 358, 383–384.
   PubMed Web of Science ®Google Scholar
• Walters, T.R., Bushore, M. and Simone, J. (1972) "Poor prognosis in Negro children with acute lymphoblastic leukaemia", Cancer 29, 210–214.
   PubMed Web of Science ®Google Scholar
• Jamroziak, K., IVIlynarski, W., Balcerczak, E., Mistygacz, M., Trelinska, J., Mirowski, M., Bodalski, J. and Robak, T. (2003) "Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia", Fur. J. Hematol., (in press).
   Google Scholar
• Hitzl, M., Drescher, S., van der Kulp, H., Schaffeler, E., Fischer, J., Schwab, M., Eichelbaum, M. and Fromm, M.F. (2001) "The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells", Pharmaco-genetics 11, 293–298.
   PubMedGoogle Scholar
• Oselin, K., Gerloff, T., Mrozikiewicz, P.M., Pahkla, R. and Roots, I. (2003) "MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes", Fundam. Clin. Pharmacol. 17, 463–469.
   PubMed Web of Science ®Google Scholar
• Fellay, J., Marzolini, C., Meaden, E.R., Back, D.J., Budin, T., Chave, J.P., Decosterd, L.A., Furrer, H., Opravil, M., Pantaleo, G., Retelska, D., Ruiz, L., Schinkel, A.H., Vernazza, P., Eap, C.B. and Telenti, A. (2002) "Response to antiretro-viral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study", Lancet 359, 30–36.
   PubMed Web of Science ®Google Scholar
• Dresher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Shwab, M., Brinkman, U., Eichelbaum, M. and Fromm, M.F. (2002) "MDR1 gene polymorphism and disposition of the P-glycoprotein substrate fexofenadine", Br. J. Clin. Pharma-col. 53, 526–534.
   PubMed Web of Science ®Google Scholar
• van den Heuvel-Eibrink, M.M., van Schaik, R.H.N., van der Heiden, I., Sonneveld, P., Pieters, R. and Wiemer, E.A.C. (2002) "MDR-1 Gene Polymorphisms G26/71 and C3435T Do Not Correlate with P-Glycoprotein Expression and Function in Acute Myeloid Leukemia (AML)", Blood 98, 308a.
   Web of Science ®Google Scholar
• Efferth, T., Sauerbrey, A., Steinbach, D., Gebhart, E., Drexler, H.G., Miyachi, H., Chitambar, C.R., Becker, C.M., Zintl, F. and Humeny, A. (2003) "Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia", Int. J. Oncol. 23, 509–517.
   PubMed Web of Science ®Google Scholar
• Nakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T., Aoyama, N., Shirakawa, T., Matsuo, M., Kasuga, M. and Okumura, K. (2002) "Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects", Clin. Pharmacol. Ther. 71, 297–303.
   PubMed Web of Science ®Google Scholar
• Goto, M., Masuda, S., Saito, H., Uemoto, S., Kiuchi, T., Tanaka, K. and Inui, K. (2002) "C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than P-gp in recipients of living-donor liver transplantation", Pharmacogenetics 12, 451–454.
   PubMedGoogle Scholar
• Siegsmund, M., Brinkmann, U., Schaffeler, E., Weirich, G., Schwab, M., Eichelbaum, M., Fritz, P., Burk, O., Decker, J., Alken, P., Rothenpieler, U., Kerb, R., Hoffmeyer, S. and Brauch, H. (2002) "Association of the P-glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors", J. Am. Soc. Nephrol. 13, 1847–1854.
   PubMed Web of Science ®Google Scholar
• Verstuyft, C., Schwab, M., Schaeffeler, E., Kerb, R., Brinkmann, U., Jaillon, P., Funck-Brentano, C. and Becquemont, L. (2003) "Digoxin pharmacoldnetics and MDR1 genetic polymorphisms", Fur. J. Clin. Pharmacol. 58, 809–812.
   Web of Science ®Google Scholar
• Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., Kasuga, M. and Okumura, K. (2001) "MDR1 genotype-related pharmacoldnetics of digoxin after single oral administration in healthy Japanese subjects", Pharmacol. Res. 18, 1400–1404.
   Google Scholar
• Morita, Y., Sakaeda, T., Horinouchi, M., Nakamura, T., Kuroda, K., Mild, I., Yoshimura, K., Sakai, T., Shirasaka, D., Tamura, T., Aoyama, N., Kasuga, M. and Okumura, K. (2003) "MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects", Pharm. Res. 20,552–556.
   PubMed Web of Science ®Google Scholar
• Anglicheau, D., Verstuyft, C., Laurent-Puig, P., Becquemont, L., Schlageter, M.H., Cassinat, B., Beaune, P., Legendre, C. and Thervet, E. (2003) "Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients", J. Am. Soc. Nephrol. 14, 1889–1896.
   PubMed Web of Science ®Google Scholar
• Yates, C.R., Zhang, W., Song, P., Li, S., Gaber, A.O., Kotb, M., Honaker, M.R., Alloway, R.R. and Meibohm, B. (2003) "The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients", J. Clin. Pharmacol. 43, 555–564.
   PubMed Web of Science ®Google Scholar
• Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., Warzok, R., Kroemer, H.K. and Cascorbi, I. (2002) "The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol", Clin. Pharmacol. Ther. 72,572–583.
   PubMed Web of Science ®Google Scholar
• von Ahsen, N., Richter, M., Grupp, C., Ringe, B., Oellerich, M. and Armstrong, V.W. (2001) "No influence of MDR-1 C3435T polymorphism or a CYP3A4 promoter poly-morphism (CYP3A4-V Allele) on dose-adjusted cyclo-sporine A trough concentrations or rejection incidence in stable renal transplant recipients", Clin. Chem. 47, 1048–1052.
   PubMed Web of Science ®Google Scholar
• Min, DJ. and Ellingrod, V.L. (2002) "C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects", Then Drug Monit. 24, 400–404.
   PubMed Web of Science ®Google Scholar
• Kerb, R., Aynacioglu, A.S., Brockmoller, J., Schlagenhaufer, R., Bauer, S., Szekeres, T., Hamwi, A., Fritzer-Szekeres, M., Baumgartner, C., Ongen, H.Z., Guzelbey, P., Roots, I. and Brinkmarm, U. (2001) "The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels", Pharmacogenomics J. 1, 204–210.
   PubMedGoogle Scholar
• Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M. and Fromm, M.F. (2002) "MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine", Br. J. Clin. Pharmacol. 53, 526–534.
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarfaty, C., Gribar, J.J. and Gottesman, M.M. (2002) "Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system", Mol. Pharmacol. 62, 1–6.
   PubMed Web of Science ®Google Scholar
• Morita, N., Yasumori, T. and Nakayama, K. (2003) "Human MDR1 polymorphism: G26/71 /A and C3435T have no effect on MDR1 transport activities", Biochem. Pharmacol. 65, 1843–1852.
   PubMed Web of Science ®Google Scholar
• Potocnik, U., Ravnik-Glavac, M. and Glavac, D. (2002) "Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability", Cell Mol. Biol. Lett. 7, 92–95.
   PubMed Web of Science ®Google Scholar
• Schwab, M., Schaeffeler, E., Marx, C., Fromm, ME, Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M., Walker, S., Cascorbi, I., Roots, I., Brinkmann, U., Zanger, U.M. and Eichelbaum, M. (2003) "Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis", Gastroenterology 124,26–33.
   PubMed Web of Science ®Google Scholar
• Calado, R.T., Falcao, R.P., Garcia, A.B., Gabellini, S.M., Zago, M.A. and Franco, RE (2002) "Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells", Haematologica 87, 564–568.
   PubMed Web of Science ®Google Scholar
• Rund, D., Azar, I. and Shperling, O. (1999) "A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease", Adv. Exp. Med. Biol. 457, 71–75.
   PubMed Web of Science ®Google Scholar
• Calado, R.T., Franco, RE, Zago, M.A. and Falcao, RE (2002) "MDR1 gene C3435T polymorphism and the risk of acquired aplastic anaemia", Br. J. Haematol. 117, 769.
   PubMed Web of Science ®Google Scholar
• Ben-Yehuda, D., Krichevsky, S., Shafran, S., Bar Cohen, S., Goldschmidt, N., Kedmi, M., Ben Neriah, S. and Rund, D. (2002) "Therapy-Related Leukemia: Clinical Characterstics and Analysis of New Molecular Risk Factors in 96 Patients", Blood 100, 324a.
   Web of Science ®Google Scholar
• Urayama, KY., Wiencke, J.K., Buffler, P.L. and Wiemels, J.L. (2002) "The role of MDR1 gene polymorphisms in the genetic susceptibility to childhood leukemia", Ann. Epidemiol. 12, 497.
   Google Scholar
• van den Heuvel-Eibrink, MM., Wiemer, E.A., de Boevere, M.J., van der Holt, B., Vossebeld, P.J., Pieters, R. and Sonneveld, P. (2001) "MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia", Blood 97, 3605–3611.
   PubMed Web of Science ®Google Scholar
• Stanulla, M., Schaeffeler, E., Schrappe, M., Rathmann, A., Arens, S., Welte, K., Eichelbaum, M., Zanger, U. and Schwab, M. (2001) "An Association between the MDR1 C3435T Polymorphism and CNS Relapse in Childhood Acute Lymphoblastic Leukemia", Blood 98, 316a.
   Web of Science ®Google Scholar
• Kafka, A., Sauer, G., Jaeger, C., Grundmann, R., Kreienberg, R., Zeillinger, R. and Deissler, H. (2003) "Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer", Int. J. Oncol. 22, 1117–1121.
   PubMed Web of Science ®Google Scholar
• Furuno, T., Landi, UT., Ceroni, M., Caporaso, N., Bernucci, I., Nappi, G., Martignoni, E., Schaeffeler, E., Eichelbaum, M., Schwab, M. and Zanger, U.M. (2002) "Expression poly-morphism of the blood—brain barrier component P-glyco-protein (MDR1) in relation to Parkinson's disease", Pharmacogenetics 12, 529–534.
   PubMedGoogle Scholar
• Drozdzik, M., Bialecka, M., Mysliwiec, K., Honczarenko, K., Stankiewicz, J. and Sych, Z. (2003) "Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease", Pharmacogenetics 13, 259–263.
   PubMedGoogle Scholar
• Roberts, R.L., Joyce, ER., Mulder, R.T., Begg, E.J. and Kennedy, M.A. (2002) "A common P-glycoprotein poly-morphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression", Pharmacogenomics J. 2, 191–196.
   PubMedGoogle Scholar
• Nasi, M., Borghi, V, Pinti, M., Bellodi, C., Lugli, E., Maffei, S., Troiano, L., Richeldi, L., Mussini, C., Esposito, R. and Cossarizza, A. (2003) "MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive WV-positive patients", AIDS 17, 1696–1698.
   PubMed Web of Science ®Google Scholar
• Ifergan, I., Bernard, NE, Bruneau, J., Alary, M., Tsoukas, C.M. and Roger, M. (2002) "Allele frequency of three functionally active polymorphisms of the MDR-1 gene in high-risk HIV-negative and HIV-positive Caucasians", AIDS 16, 2340–2342.
   PubMed Web of Science ®Google Scholar
• Zheng, H., Webber, S., Zeevi, A., Schuetz, E., Zhang, J., Bowman, P., Boyle, G., Law, Y, Miller, S., Lamba, J. and Burckart, G.J. (2003) "Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms", Am. J. Transplant. 3, 477–483.
   PubMed Web of Science ®Google Scholar
• Gwee, P.C., Tang, K., Chua, J.M., Lee, E.J., Chong, S.S. and Lee, C.G. (2003) "Simultaneous genotyping of seven single-nucleotide polymorphisms in the MDR1 gene by single-tube multiplex minisequencing", Clin. Chem. 49, 672–676.
   PubMed Web of Science ®Google Scholar
• Song, P., Li, S., Meibohm, B., Gaber, A.O., Honaker, MR., Kotb, M. and Yates, C.R. (2002) "Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay", AAPS PharmSci. 4, 29.
   Google Scholar
• Nauck, M., Stein, U., von Karger, S., Marz, W. and Wieland, H. (2000) "Rapid detection of the C3435T polymorphism of multidrug resistance gene 1 using fluorogenic hybridization probes", Clin. Chem. 46, 1995–1997.
   PubMed Web of Science ®Google Scholar
• Evans, WE., Relling, UV, Rodman, J.H., Crom, W.R., Boyett, J.M. and Pui, C.H. (1998) "Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia", N. Engl. J. Med. 338, 499–505.
   PubMed Web of Science ®Google Scholar